Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $113.19 billion. The enterprise value is $123.20 billion.
Important Dates
The last earnings date was Wednesday, February 4, 2026, before market open.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 0.58% in one year.
| Current Share Class | 1.48B |
| Shares Outstanding | 1.48B |
| Shares Change (YoY) | +0.58% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 93.71% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 39.32 and the forward PE ratio is 22.02. BSX's PEG ratio is 1.30.
| PE Ratio | 39.32 |
| Forward PE | 22.02 |
| PS Ratio | 5.64 |
| Forward PS | 5.03 |
| PB Ratio | 4.67 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 24.96 |
| PEG Ratio | 1.30 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 42.51 |
| EV / Sales | 6.14 |
| EV / EBITDA | 23.08 |
| EV / EBIT | 31.02 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.49.
| Current Ratio | 1.62 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | n/a |
| Interest Coverage | 11.38 |
Financial Efficiency
Return on equity (ROE) is 12.45% and return on invested capital (ROIC) is 10.59%.
| Return on Equity (ROE) | 12.45% |
| Return on Assets (ROA) | 5.98% |
| Return on Invested Capital (ROIC) | 10.59% |
| Return on Capital Employed (ROCE) | 10.39% |
| Weighted Average Cost of Capital (WACC) | 7.35% |
| Revenue Per Employee | $340,237 |
| Profits Per Employee | $49,119 |
| Employee Count | 59,000 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.18 |
Taxes
In the past 12 months, BSX has paid $493.00 million in taxes.
| Income Tax | 493.00M |
| Effective Tax Rate | 14.56% |
Stock Price Statistics
The stock price has decreased by -28.11% in the last 52 weeks. The beta is 0.66, so BSX's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -28.11% |
| 50-Day Moving Average | 90.36 |
| 200-Day Moving Average | 99.27 |
| Relative Strength Index (RSI) | 30.92 |
| Average Volume (20 Days) | 20,077,538 |
Short Selling Information
The latest short interest is 28.28 million, so 1.91% of the outstanding shares have been sold short.
| Short Interest | 28.28M |
| Short Previous Month | 20.01M |
| Short % of Shares Out | 1.91% |
| Short % of Float | 1.91% |
| Short Ratio (days to cover) | 2.44 |
Income Statement
In the last 12 months, BSX had revenue of $20.07 billion and earned $2.90 billion in profits. Earnings per share was $1.94.
| Revenue | 20.07B |
| Gross Profit | 13.81B |
| Operating Income | 3.97B |
| Pretax Income | 3.39B |
| Net Income | 2.90B |
| EBITDA | 5.34B |
| EBIT | 3.97B |
| Earnings Per Share (EPS) | $1.94 |
Full Income StatementBalance Sheet
The company has $1.97 billion in cash and $11.97 billion in debt, with a net cash position of -$10.01 billion or -$6.74 per share.
| Cash & Cash Equivalents | 1.97B |
| Total Debt | 11.97B |
| Net Cash | -10.01B |
| Net Cash Per Share | -$6.74 |
| Equity (Book Value) | 24.47B |
| Book Value Per Share | 16.34 |
| Working Capital | 3.36B |
Full Balance SheetCash Flow
| Operating Cash Flow | 4.53B |
| Capital Expenditures | -876.00M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 68.78%, with operating and profit margins of 19.78% and 14.44%.
| Gross Margin | 68.78% |
| Operating Margin | 19.78% |
| Pretax Margin | 16.86% |
| Profit Margin | 14.44% |
| EBITDA Margin | 26.60% |
| EBIT Margin | 19.78% |
| FCF Margin | n/a |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.58% |
| Shareholder Yield | -0.58% |
| Earnings Yield | 2.56% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for BSX is $109.15, which is 43.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $109.15 |
| Price Target Difference | 43.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 10.68% |
| EPS Growth Forecast (5Y) | 23.84% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 5.69 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.69 |
| Piotroski F-Score | 7 |
